DuPont de Nemours, Inc. DD
DuPont de Nemours, Inc. is a plastic materials, synth resins & nonvulcan elastomers issuer listed as DD on NYSE. This free Atlas page links SEC CIK 1666700, Nasdaq Trader and TradingView NYSE:DD, related symbols and the workstation route before a full report is run.
DD public profile
Plastic materials, synth resins & nonvulcan elastomers issuer. Atlas tracks DD through its NYSE listing record, chart route and source links.
DD trades on NYSE. SEC CIK 1666700. Chart route NYSE:DD.
Nasdaq Trader is the listing identity source for DuPont de Nemours, Inc.. Atlas files DD under USA Stocks for browsing. The canonical public URL is /stocks/DD/. The workstation link below opens the fuller research run.
Market Wit preview
DuPont's most useful June fact is not a slogan, it is the balance sheet with its sleeves rolled up: $1.68B of revenue from contracts with customers, $161.0M of net income attributable to the parent, and diluted EPS of $0.39 for the 10-Q period ending 2026-03-31. That is the cleaner way to read this equity than staring lovingly at a ticker and pretending it has a personality. DuPont says it serves healthcare, water and industrial segments with engineered products, application development and manufacturing; the 10-Q adds the less glamorous truth that substantially all revenue is derived from product sales. In other words, this is still a company that has to make things, ship things and collect cash, which is a useful antidote to any market sentence...
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for DD.
What changed for DuPont de Nemours, Inc. today
The strongest current development on the supplied rail is DuPont’s 2026-05-26 8-K: DuPont de Nemours, Inc. said a press release announced Board of Directors approval of a Reverse Stock Split. That sits after the 2026-05-05 8-K announcing first quarter 2026 results and before June SEC filing trail, including a 11-K filed on 2026-06-12 and several Form 4 filings dated 2026-06-02.
DuPont is not just a ticker in this source pack. The official issuer rail describes the company as a leading solutions provider for healthcare, water and a broad range of industrial segments, powered by high-performance engineered products, application development and manufacturing. The 10-Q gives the commercial spine of that description: substantially all of DuPont’s revenue is derived from product sales.
The latest supplied filed financials come from the 10-Q for the period ending 2026-03-31. DuPont reported Revenue from Contract with Customer, Excluding Assessed Tax of $1.68B, Net Income Attributable to Parent of $161.0M, diluted EPS of $0.39 and diluted weighted average shares outstanding of 412.8M. The same rail shows assets of $21.45B, liabilities of $7.21B, parent stockholders’ equity of $14.04B, cash and cash equivalents of $710.0M, R&D expense of $47.0M and net inventory of $1.21B.
No chart route or price level is supplied in the evidence, so the market mechanism here has to be read through filings, issuer releases and the official SEC register rather than invented candles. The capital structure item is the reverse stock split approval from the May 26 8-K; the operating mechanism is product sales across healthcare, water and industrial end markets; the accounting mechanism is the filed 10-Q and SEC companyfacts rail.
What changed is visible but narrow: DuPont reported first quarter 2026 results on May 5, filed the related 10-Q, announced board approval of a reverse stock split on May 26, then added June SEC filings including Form 4s and a 11-K. What remains unproven on this rail is end-market growth by segment, customer demand, margin bridge, free cash flow, order trends and any share price reaction. The supplied evidence supports a disciplined filing story, not a trading call.
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
Atlas has no approved static OHLC cache attached for DD yet, so the profile renders the verified TradingView chart route directly and keeps the full-chart link as fallback.
Run an Atlas research workflow on DD
FreedomCore Atlas operates research workstation templates for company snapshots, DCF, LBO, KYC, NAV tie-outs, and council-grade equity briefs. Each workflow uses public-source filings and structured prompts.
Open Atlas workstation ->Save DD research and exports
Free Atlas users can run full browser research reports from the workstation. Atlas Pro adds 25 custom runs a day, saved research history, email delivery, PDF/CSV exports, and a 25-symbol watchlist. £12/mo founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
DD FAQ
What is DuPont de Nemours, Inc. (DD)?DuPont de Nemours, Inc. is a plastic materials, synth resins & nonvulcan elastomers issuer listed as DD on NYSE. This free Atlas page links SEC CIK 1666700, Nasdaq...
DuPont de Nemours, Inc. is a plastic materials, synth resins & nonvulcan elastomers issuer listed as DD on NYSE. This free Atlas page links SEC CIK 1666700, Nasdaq Trader and TradingView NYSE:DD, related symbols and the workstation route before a full report is run.
What does Atlas show for DD?The DD page gives the free Atlas profile for DuPont de Nemours, Inc.: listing identity, chart route, related symbols, source authority and the workstation route. The...
The DD page gives the free Atlas profile for DuPont de Nemours, Inc.: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is NYSE:DD; the stable page route is /stocks/DD/. Visible source links include SEC EDGAR CIK 1666700, Nasdaq Trader and TradingView NYSE:DD. Atlas files DD under USA Stocks for browsing.
How often is the DD page updated?The /stocks/DD/ URL is stable. Atlas updates the free DD page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or...
The /stocks/DD/ URL is stable. Atlas updates the free DD page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or published public answer changes.
Which sources does Atlas use for DD?For DD, Atlas starts with SEC EDGAR CIK 1666700, Nasdaq Trader and TradingView NYSE:DD. The SEC CIK 1666700 route is the issuer filing anchor. Nasdaq Trader confirms...
For DD, Atlas starts with SEC EDGAR CIK 1666700, Nasdaq Trader and TradingView NYSE:DD. The SEC CIK 1666700 route is the issuer filing anchor. Nasdaq Trader confirms the listed-symbol identity used by the public directory. NYSE:DD is the chart route shown on the free page. Full workstation reports may add fresh filings, issuer documents, holdings, news, macro context or model-reviewed notes when available.
Can Atlas run a full research brief on DD?Yes. The workstation can open DD, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open DD, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this DD page investment advice?No. The DD page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a...
No. The DD page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-06-20. Browse FreedomCore Atlas research notes →